Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pizza

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Archives De L'Institut Pasteur De Tunis|July 1, 1994
Development of the new acellular recombinant pertussis vaccineR Rappuoli, M Pizza, A Podda, et al.
The Tokai Journal of Experimental and Clinical Medicine|January 1, 1988
Engineering bacterial toxin for the development of new vaccine against pertussisA Bartoloni, M Pizza, R Gross, et al.
Clinical and Vaccine Immunology : CVI|January 30, 2015
A large portion of meningococcal antigen typing system-negative meningococcal strains from spain is killed by sera from adolescents and infants immunized with 4CMenBR Abad, A Biolchi, M Moschioni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2000
Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activityE J Ryan, E McNeela, M Pizza, et al.
Developments in Biological Standardization|April 29, 1998
Adjuvant effect of non-toxic mutants of E. coli heat-labile enterotoxin following intranasal, oral and intravaginal immunizationM T De Magistris, M Pizza, G Douce, et al.
Infection and Immunity|January 1, 1997
Protease susceptibility and toxicity of heat-labile enterotoxins with a mutation in the active site or in the protease-sensitive loopV Giannelli, M R Fontana, M M Giuliani, et al.
International Journal of Medical Microbiology : IJMM|December 9, 2000
LTK63 and LTR72, two mucosal adjuvants ready for clinical trialsM Pizza, M M Giuliani, M R Fontana, et al.
Vaccine|August 5, 2000
IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxinM R Fontana, E Monaci, L Yanqing, et al.
Infection and Immunity|August 19, 2000
Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coliH Koprowski, M M Levine, R J Anderson, et al.
The Journal of Experimental Medicine|May 16, 1998
Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activityM M Giuliani, G Del Giudice, V Giannelli, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Archives De L'Institut Pasteur De Tunis|July 1, 1994
Development of the new acellular recombinant pertussis vaccineR Rappuoli, M Pizza, A Podda, et al.
The Tokai Journal of Experimental and Clinical Medicine|January 1, 1988
Engineering bacterial toxin for the development of new vaccine against pertussisA Bartoloni, M Pizza, R Gross, et al.
Clinical and Vaccine Immunology : CVI|January 30, 2015
A large portion of meningococcal antigen typing system-negative meningococcal strains from spain is killed by sera from adolescents and infants immunized with 4CMenBR Abad, A Biolchi, M Moschioni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2000
Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activityE J Ryan, E McNeela, M Pizza, et al.
Developments in Biological Standardization|April 29, 1998
Adjuvant effect of non-toxic mutants of E. coli heat-labile enterotoxin following intranasal, oral and intravaginal immunizationM T De Magistris, M Pizza, G Douce, et al.
Infection and Immunity|January 1, 1997
Protease susceptibility and toxicity of heat-labile enterotoxins with a mutation in the active site or in the protease-sensitive loopV Giannelli, M R Fontana, M M Giuliani, et al.
International Journal of Medical Microbiology : IJMM|December 9, 2000
LTK63 and LTR72, two mucosal adjuvants ready for clinical trialsM Pizza, M M Giuliani, M R Fontana, et al.
Vaccine|August 5, 2000
IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxinM R Fontana, E Monaci, L Yanqing, et al.
Infection and Immunity|August 19, 2000
Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coliH Koprowski, M M Levine, R J Anderson, et al.
The Journal of Experimental Medicine|May 16, 1998
Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activityM M Giuliani, G Del Giudice, V Giannelli, et al.
Pageof 8